First use of convalescent plasma to treat severe COVID-19 disease
By Michael Woodhead
2 Apr 2020
Trials of convalescent plasma to treat severe COVID-19 disease have started at US hospitals following fast track approval of the experimental therapy by the FDA. Clinicians at Houston Methodist Hospital in Texas say they are the first to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. Dr Eric Salazar, principal ...